𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment with atorvastatin reduces serum adipocyte-fatty acid binding protein value in patients with hyperlipidaemia

✍ Scribed by M. Karpisek; D. Stejskal; H. Kotolova; P. Kollar; G. Janoutova; R. Ochmanova; L. Cizek; D. Horakova; R. Ben Yahia; R. Lichnovska; V. Janout

Book ID
108713528
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
151 KB
Volume
37
Category
Article
ISSN
0014-2972

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Serum adipocyte-fatty acid binding prote
Serum adipocyte-fatty acid binding protein discriminates patients with permanent and temporary body weight loss
✍ D. Stejskal; M. Karpisek; J. Bronsky πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 71 KB

## Abstract Adipocyte‐fatty acid binding protein (A‐FABP) is a biomarker of adiposity and metabolic syndrome. The aim of our work was to investigate the effect of weight reduction on serum A‐FABP value. In the study, we analyzed a group of 189 probands suffering from obesity (102 women and 87 men;

Prognostic value of combination of heart
Prognostic value of combination of heart-type fatty acid-binding protein and ischemia-modified albumin in patients with acute coronary syndromes and normal troponin T values
✍ Cui Liyan; Zhang Jie; Hu Xiaozhou πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 93 KB

## Abstract Recent studies have suggested that heart‐type fatty acid‐binding protein (H‐FABP) may detect ongoing myocardial damage involved in the progression of acute coronary syndromes (ACS). This study was prospectively designed to examine whether the combination of H‐FABP, a marker for ongoing